Bryn Mawr Capital Management LLC Acquires 6,248 Shares of Maximus, Inc. (NYSE:MMS)

Bryn Mawr Capital Management LLC grew its holdings in Maximus, Inc. (NYSE:MMS) by 290.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 8,400 shares of the health services provider’s stock after purchasing an additional 6,248 shares during the quarter. Bryn Mawr Capital Management LLC’s holdings in Maximus were worth $627,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Principal Financial Group Inc. raised its holdings in shares of Maximus by 1.1% in the 4th quarter. Principal Financial Group Inc. now owns 165,781 shares of the health services provider’s stock valued at $12,376,000 after purchasing an additional 1,738 shares in the last quarter. State of New Jersey Common Pension Fund D raised its holdings in shares of Maximus by 21.2% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 26,302 shares of the health services provider’s stock valued at $1,963,000 after purchasing an additional 4,597 shares in the last quarter. Allworth Financial LP raised its stake in shares of Maximus by 1,638.4% during the 4th quarter. Allworth Financial LP now owns 1,495 shares of the health services provider’s stock worth $116,000 after acquiring an additional 1,409 shares in the last quarter. Rhumbline Advisers raised its stake in shares of Maximus by 6.1% during the 4th quarter. Rhumbline Advisers now owns 205,259 shares of the health services provider’s stock worth $15,323,000 after acquiring an additional 11,772 shares in the last quarter. Finally, V Square Quantitative Management LLC raised its stake in shares of Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after acquiring an additional 180 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.

Analysts Set New Price Targets

MMS has been the subject of several recent analyst reports. StockNews.com lowered shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a research note on Thursday, January 2nd.

Maximus Trading Down 1.2 %

NYSE MMS opened at $65.95 on Friday. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The firm has a market cap of $3.73 billion, a PE ratio of 14.18 and a beta of 0.72. The company has a 50 day moving average price of $73.79 and a 200 day moving average price of $81.72. Maximus, Inc. has a 52 week low of $64.53 and a 52 week high of $93.97.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, sell-side analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Saturday, February 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.82%. Maximus’s payout ratio is 25.81%.

Insider Buying and Selling at Maximus

In other Maximus news, insider Michelle F. Link sold 2,208 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total transaction of $163,016.64. Following the transaction, the insider now owns 6,567 shares in the company, valued at approximately $484,841.61. This represents a 25.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have purchased 7,063 shares of company stock worth $502,017. 1.60% of the stock is owned by corporate insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.